SELLAS Life Sciences Grou... (SLS)

NASDAQ: SLS · Real-Time Price · USD

1.60

0.05 (3.23%)

At close: May 01, 2025, 3:59 PM

1.69

5.30%

Pre-market: May 02, 2025, 07:10 AM EDT

SELLAS Life Sciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	13.99M	2.53M	17.13M	21.36M	35.3M	7.28M	5.34M	2.32M	18.08M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	-184K	-152K	-1.15M	n/a	n/a	n/a	n/a
Other Long-Term Assets	266K	275K	399K	594K	614K	536K	-765K	925K	96K
Receivables	n/a	n/a	n/a	n/a	n/a	308K	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	465K	573K	n/a	n/a	n/a
Other Current Assets	n/a	499K	330K	1.44M	1.35M	184K	291K	10.43M	85K
Total Current Assets	16.33M	3.17M	17.76M	23.04M	36.92M	8.24M	5.84M	13.09M	37.5M
Property-Plant & Equipment	925K	858K	874K	723K	896K	217K	n/a	n/a	199K
Goodwill & Intangibles	1.91M	1.91M	1.91M	1.91M	7.61M	7.61M	10.41M	19.51M	28.02M
Total Long-Term Assets	3.1M	3.05M	3.19M	3.23M	9.12M	8.37M	11.08M	20.44M	28.31M
Total Assets	19.43M	6.22M	20.94M	26.27M	46.05M	16.61M	16.91M	33.53M	65.81M
Account Payables	3.5M	5.64M	3.36M	2.14M	4.66M	3.9M	3.75M	11.69M	n/a
Deferred Revenue	n/a	n/a	n/a	2.48M	5.6M	n/a	n/a	4.31M	5.24M
Short-Term Debt	544K	n/a	372K	198K	166K	217K	n/a	8.38M	1.71M
Other Current Liabilities	1.82M	6.16M	9.97M	952K	935K	389K	8K	1.49M	2.01M
Total Current Liabilities	9.51M	13.73M	15.52M	4.98M	12.34M	5.29M	5.97M	24.57M	30.4M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.61M	5.66M
Other Long-Term Liabilities	n/a	n/a	4K	336K	4.69M	4.96M	5.34M	2.6M	-5.66M
Total Long-Term Liabilities	457K	460K	577K	946K	5.75M	5.23M	5.7M	6.89M	6.76M
Total Liabilities	9.97M	14.2M	16.09M	5.93M	18.09M	10.52M	11.67M	31.46M	37.15M
Total Debt	1M	906K	945K	808K	991K	217K	n/a	10.99M	16.4M
Common Stock	7K	3K	2K	2K	1K	5K	2K	1K	15K
Retained Earnings	-248.13M	-217.24M	-179.9M	-138.6M	-117.9M	-101.15M	-81.86M	-54.19M	-302.93M
Comprehensive Income	n/a	n/a	n/a	n/a	-0.00	n/a	n/a	0.00	n/a
Shareholders Equity	9.46M	-7.98M	4.85M	20.35M	27.96M	6.09M	5.25M	2.07M	28.66M
Total Investments	n/a	-1	-184K	-152K	-1.15M	n/a	n/a	n/a	n/a